H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodTop Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| NOSTRUM LABORATORIES, INC. | 2 | $132,149 | $128,300 - $135,998 | 100.0% |
| GRANULES PHARMACEUTICALS, INC | 1 | $160,000 | $160,000 - $160,000 | 100.0% |
| INVAGEN PHARMACEUTICALS, INC | 1 | $142,908 | $142,908 - $142,908 | 100.0% |
| Aurobindo Pharma USA, Inc. | 1 | $120,000 | $120,000 - $120,000 | 100.0% |
| OCIM Pharmaceuticals LLC | 1 | $120,000 | $120,000 - $120,000 | 100.0% |
| Pharm OPS. Inc | 1 | $120,000 | $120,000 - $120,000 | 100.0% |
| SIGMAPHARM LABORATORIES, LLC | 1 | $114,566 | $114,566 - $114,566 | 100.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| Manager | 7 | $120,000 | $114,566 - $142,908 |
| Director | 1 | $160,000 | $160,000 - $160,000 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| Kansas City | MO | 2 | $132,149 |
| Central lslip | NY | 1 | $142,908 |
| Chantilly | VA | 1 | $160,000 |
| Bensalem | PA | 1 | $114,566 |
| Phillipsburg | NJ | 1 | $120,000 |
| Pine Brook | NJ | 1 | $120,000 |
| Durham | NC | 1 | $120,000 |
These roles are variations of MANAGER, ANALYTICAL R&D with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| MANAGER, ANALYTICAL R&D | 33 | $114,738 | |
| SENIOR DIRECTOR, ANALYTICAL R&D | 3 | $132,497 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2021 | 5 | $120,000 | 100.0% |
| 2024 | 1 | $120,000 | 100.0% |
| 2025 | 2 | $151,454 | 100.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| NOSTRUM LABORATORIES, INC. | 2 | $132,149 | 100.0% |
| GRANULES PHARMACEUTICALS, INC | 1 | $160,000 | 100.0% |
| INVAGEN PHARMACEUTICALS, INC | 1 | $142,908 | 100.0% |
| Aurobindo Pharma USA, Inc. | 1 | $120,000 | 100.0% |
| OCIM Pharmaceuticals LLC | 1 | $120,000 | 100.0% |